Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,778 Jan 1 – Oct 27, 2026
- Disclosed funding
- $349.4B 3714 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| K Kris@WorkCompany profile AI-native Go-To-Market (GTM) execution platform for enterprise revenue teams AI-native Go-To-Market (GTM) execution platform for enterprise revenue teams | $3M | Seed | AI | India | Investors | |
| S Builds AI-powered go-to-market engineering systems for revenue teams | $6M | Seed | AI | Israel | Investors | |
| T TurbineCompany profile Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation | $25M | Series B | Biotech | Hungary | Investors | |
| SA Provides AI-powered guest communications platform for hospitality industry | $36M | Series B | Ecommerce | United States | Investors | |
| S StraionCompany profile Builds AI context-layer platform to govern and validate AI-generated code for enterprises Builds AI context-layer platform to govern and validate AI-generated code for enterprises | €1.1M | Seed | AI | Austria | Investors | |
| AA Axelera AICompany profile Develops AI acceleration hardware for edge computing and data center applications Develops AI acceleration hardware for edge computing and data center applications | $250M | Growth | Hardware | Netherlands | Investors | |
| S Provides AI-powered K-12 curriculum and online learning platform | $28M | Growth | Edtech | United States | Investors | |
| SM Slate MedicinesCompany profile Advancing next-generation therapeutics for migraine and other headache disorders Advancing next-generation therapeutics for migraine and other headache disorders | $130M | Series A | Biotech | United States | Investors | |
| B Develops AI-powered imaging tools for stroke and lung fibrosis | $6.8M | Series C+ | Healthtech | United Kingdom | Investors | |
| MO Myrias OpticsCompany profile Develops all-inorganic additive nanoimprint technology for wafer-level metaoptics and waveguides Develops all-inorganic additive nanoimprint technology for wafer-level metaoptics and waveguides | $2.1M | Seed 1Seed | Hardware | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
162rounds5led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
113rounds22led - 3General Catalyst
Hyperbolic, Re:Build, Matiks
105rounds14led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Hex, Nevis, Warhound
74rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →